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METHODS: Sixty rats were randomly divided into three groups, with 20 rats in the
sham group (SH group). 5/6 nephrectomy was performed on 40 rats in the uremia
model group, and histopathology confirmed that the model was successfully
established, which were randomly divided into the uremia model group (UR group, 20
rats), probiotics intervention group (UP group, rats), and intestinal tissues were
extracted. Rt-PCR was performed to detect the expression of mir-223 mRNA in the
intestinal tissues of each group. Expression of NLRP3, caspase-1, IL-1b, JAM-1,
Occludin and claudin-1 in intestinal epithelial cells were detected by Western blotting.
RESULTS: The expression of mir-223 mRNA in the intestinal tissues of uremic model
rats was significantly decreased and increased after the intervention of probiotics
(figure 1).Western blotting found that the expression of intestinal tissue NLRP3,
caspase-1, IL-1b was significantly increased in the uremic group, and after probiotics
intervention, the expression of NLRP3 inflammasome was decreased and the
expression of tight junction protein was improved (Fig 1), while the expression of
intestinal tight junction protein JAM-1, Occludin, claudin-1 was decreased (Fig 2, Fig
3).
CONCLUSIONS: Mir-223/NLRP3 may be involved in affecting the intestinal barrier of
uremia. Probiotics can improve the intestinal barrier function, which may be related to
the mir-223 /NLRP3 pathway, and may provide a new treatment idea for the intestinal
barrier dysfunction of uremia -chronic inflammation.
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INTRODUCTION: Muscle wasting and obesity are common and important predictors
of long-term outcomes in dialysis patients. The aim of this study was to explore
whether the lean tissue index (LTI) and fat tissue index (FTI) are associated with
health-related quality of life (HRQOL) in dialysis patients.
METHODS: This prospective observational study analyzed data from 982 dialysis
patients who participated in the Quality of Life Dialysis study in Korea. Body
composition was measured using bioimpedance spectroscopy, and HRQOL was
examined at baseline and after 12 months. The patients were categorized into quartiles
according to LTI and FTI. Low LTI was defined as the lowest quartile, and high FTI as
the highest quartile. Associations of LTI and FTI with HRQOL scores and with lower
HRQOL scores at baseline and at 12 months were identified
RESULTS: Body mass index reflects FTI rather than LTI, and low LTI frequently
accompanied high FTI (46.7%) and normal weight (67.8%). Multivariate analysis
showed that low LTI was independently associated with baseline and follow-up
HRQOL scores. In addition, high FTI was significantly associated with baseline
HRQOL scores and with follow-up physical health and kidney disease component
scores.
Table 1. Multivariate regression analysis for lower HRQOL scores
Variables Low PCS Low MCS Low KDCS
Odds ratio (95% CI)
Baseline
Age 1.03 (0.99; 1.06) 0.98 (0.95; 1.01) 0.99 (0.95; 1.03)
CCI 1.40 (1.06; 1.95)* 1.49 (1.11; 2.02)** 1.37 (1.00;1.86)*
Diabetes 1.44 (1.01; 2.21)* 1.68 (1.13; 2.31)* 2.00 (1.40; 2.89)**
Mode (HD vs. PD) 0.88 (0.64; 1.46) 0.91 (0.62; 1.35) 1.18 (0.78; 1.79)
Log-hsCRP 1.23(0.87; 1.73) 1.29 (1.03; 1.62)* 0.97 (0.77; 1.22)
Albumin 0.57 (0.38; 0.86)** 1.15 (0.76; 1.73) 0.80 (0.53; 1.20)
Low LTI (Q1) 2.74 (1.67; 4.49)** 1.63 (1.22; 2.29)* 1. 94 (1.19; 3.17)**
High FTI (Q4) 2.09 (1.22; 3.59)** 1.70 (1.27; 2.38)* 1.45 (0.99; 2.12)
At 12 months
Age 1.04 (1.01; 1.07)* 1.00 (0.98; 1.03) 1.00 (0.98; 1.03)
Diabetes 1.62 (1.17; 2.22)* 1.09 (0.80; 1.49) 1.23 (0.90; 1.68)
Mode (HD vs. PD) 0.55 (0.35; 0.88)* 0.62 (0.41; 0.95)* 1.83 (1.21; 2.78)*
Albumin 0.58 (0.39; 0.82)* 0.60 (0.40; 0.89)* 0.55 (0.38; 0.79)*
Low LTI (Q1) 1.96 (1.38; 2.78)** 1.51 (1.07; 2.13)* 1.94 (1.38; 2.71)**
High FTI (Q4) 1.36 (1.00; 2.06)* 0.81 (0.53; 1.22) 1.52 (1.01; 2.28)*
CONCLUSIONS: Low LTI and high FTI negatively affect baseline and follow-up
HRQOL in dialysis patients.
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INTRODUCTION: Hemodialysis has a catabolic effect caused by a significant increase
in basal metabolism within 3-4 hours post-treatment (Cuppari, 2010), and also by
inflammation, protein losses to the dialysate and blood retention in the circuit and
philter. It is estimated that in high-flux HD there is a loss of free amino acids (AA) of
8.0g 62.8g to 9.362.7g to the dialysate (Ikizler,1994), which contributes to an increase
in protein requirements.
We intend to analyze whether an intradialytic snack model, subject to the
patient&#39;s autonomy of choice, is adequate to compensate the estimated AA losses
to the dialysate. As a secondary objective, it was intended to analyze the mean energy
and phosphorus contribution of these spontaneous consumptions and also to compare
it with some oral nutritional supplements.
METHODS: It was analyzed the intradialytic nutritional intake of protein, energy and
phosphorus of the snack model implemented in one hemodialysis clinic. The intake
inquiry was performed on all patients who attended the treatment in one of the 3 to 4
daily shifts of the Wednesday and Thursday of a mid-week of July and October 2015
and of March 2016. It was considered the nutritional composition information of the
foods, in the amounts actually eaten, declared by the manufacturer, and when they
were not available, it was used the Portuguese Food Composition Table.
RESULTS: 431 spontaneous consumptions were analyzed, 390 referring to day shifts
and 41 referring to night shifts. The mean nutritional profile was 1462g of protein,
382640kCal, and 255638mg of organic and inorganic P, and the nocturnal shifts were
1961g of protein, 549691kCal, and 377635mg of P organic and inorganic. The
nutritional disparity in night shifts was due to the amount available in this snack
model, up to 2 times daytime snacks. In the 6 days analyzed there were no snack
intolerances by the patients.
CONCLUSIONS: The intradialytic snack, in this model and as a measure of comfort,
allows us to compensate for the estimated increase of the protein needs related to losses
of AA for the dialysate, in the day and night shifts. The measured protein and energetic
profile is comparable to some commercial oral nutritional supplements (hypercaloric
formulas), however, food intake is more physiological, with better tolerance and
adherence. Taking into account this mineral contribution may help in the decision of
prescribing intradialytic phosphate binders.
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INTRODUCTION: Cardiovascular (CV) events are the main causes of death in end-
stage renal disease (ESRD) patients on dialysis. It has been hypothesized that
lipoproteins’ quality (size, composition and functionality) may be more important as
CV disease risk factor than their total circulating levels. In fact, smaller low-density
lipoprotein (LDL) subpopulations are more atherogenic than larger LDL
subpopulations. Treatment with statins provides CV protection by reducing the levels
of LDL cholesterol (LDLc); however, in ESRD patients on dialysis, the reduction in
LDLc has not been associated with a significant reduction in CV events. Given the
importance of LDL quality, our aim was to evaluate in ESRD patients on dialysis the
effects of statins on LDL subfractions and on inflammation, a hallmark of ESRD.
METHODS: This study included 194 ESRD patients on dialysis; 105 (54.1%) were
under statins therapy and 89 (45.9%) were not receiving lipid-lowering drugs. We
evaluated high-sensitivity C-reactive protein (hsCRP), interleukin(IL)-6, lipid profile
and lipoprotein fractions and subfractions, namely LDL subfractions.
RESULTS: Patients under statins therapy, compared to patients not receiving satins,
presented lower levels of total cholesterol (TC), LDLc, TC/high-density lipoprotein
(HDL)c, LDLc/HDLc, IL-6 and hsCRP; the evaluation of lipoprotein subpopulations
showed higher values of intermediate-density lipoprotein (IDL)-B, and no significant
alterations in very-low-density lipoprotein (VLDL), in larger and smaller LDL, or in
LDL size.
CONCLUSIONS: Our data showed that statin therapy, actually, induces a reduction in
LDLc levels and in the inflammatory process characteristic of the uremic milieu, but it
is unable to change LDL subfractions profile. In fact, the percentages of smaller and
denser LDL particles, the most atherogenic LDL subfractions, do not decrease with
statins therapy; thus, the unaltered profile of LDL subpopulations may contribute to
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explain the limited benefits of statins therapy on CV events in ESRD patients on
dialysis.
This work was supported by the Applied Molecular Biosciences Unit (UCIBIO), which
is financed by national funds from FCT/MCTES (UID/MULTI/04378/2019) and North
Portugal Regional Coordination and Development Commission (CCDR-N)/
NORTE2020/Portugal 2020 (Norte-01-0145-FEDER-000024).
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INTRODUCTION: Oxidative stress (OS) and chronic inflammation are common
complications of chronic kidney disease patients undergoing haemodialysis (HD) that
contribute to a high cardiovascular morbidity and mortality of these patients. In HD
patients the OS may result from retention of uremic toxins, diet lacking antioxidants,
increased consumption of antioxidants to face OS and loss of antioxidants during HD
treatment. The long contact of blood with dialysis materials, may trigger leukocyte
activation leading to accumulation of reactive oxygen species and development of OS.
Several approaches have been studied to diminish inflammation and OS-associated
complications in HD patients, namely by antioxidant supplementation or by
development of coated HD membranes with antioxidant and/or anti-inflammatory
compounds. Antioxidant alpha-lipoic acid (ALA) and its reduced form represents an
ideal redox couple. Both forms effectively quench free radicals, in lipid and aqueous
media, and the reduced form is able to regenerate other antioxidants. Due to these
advantages, ALA is widely used as supplement for prevention of various chronic
diseases associated with OS. Moreover, ALA therapy showed decrease of OS
biomarkers in chronic kidney disease patients under HD. Preliminary studies by our
group showed that a polysulfone (PS) membrane enriched with ALA presented good
separation characteristics and antioxidant activity; in accordance, the aims of the
present work were to further strength the promising properties of this coated PS
membrane and to evaluate its biocompatibility.
METHODS: Membrane structure was observed by scanning electron microscopy;
antioxidant activity and time stability were evaluated by ferric reduction antioxidant
assay. Membrane biocompatibility, contact angle measurement, haemolysis and
platelet activation, were carried out.
RESULTS: Our data showed that ALA coated PS membrane is stable under storing
conditions (dark, 4C); variation in antioxidant activity within 8 weeks did not exceed
3.5%; the separation of biomolecules fulfilled requests for HD membrane (molecular
weight cut-off 66 kDa); the membrane contact angle was< 60, showing a
hydrophilic character. After 3 hours of incubation of controls and ALA coated HD
membranes with whole blood, haemolysis and platelet activation showed similar
values, when compared to negative controls, suggesting the biocompatibility of the
membrane.
CONCLUSIONS: Our data show ALA coating PS membrane as a promising
biocompatible approach to diminish OS-related complications and to reduce the high
mortality rate in chronic disease patients on HD. Our data show ALA coating PS
membrane as a promising biocompatible approach to diminish OS-related
complications and to reduce the high mortality rate in chronic disease patients on HD.
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HEMODIALYSIS PATIENTS
Zauresh Amreyeva1, Gulnar Chingayeva1, Assya Kanatbayeva1, Abai Shepetov1,
Elmira Alimzhanova1, Makpal Kulkayeva1
1Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
INTRODUCTION: In Kazakhstan the number of geriatric patients on maintenance
hemodialysis (MHD) has been increasing. Protein-energy wasting (PEW) is prevalent
complication in these patients. The primary objectives of this study were to evaluate the
prevalence of PEW in elderly patients on MHD by using different nutritional
assessment tools and assess their association with clinical and laboratory
measurements. A secondary objective was to investigate the relationship between
nutritional status and frailty among these patients.
METHODS: A multicenter cross-sectional study included 65 patients aged 65 years
undergoing HD for at least 3 months in 7 outpatient HD facilities in Almaty,
Kazakhstan. The study was performed from July to September 2018. Nutritional status
of patients was evaluated by using Mini Nutritional assessment (MNA), Malnutrition-
Inflammation Score (MIS), and anthropometric measurements (body mass index
(BMI), triceps skinfold (TSF), mid-arm muscle circumference (MAMC)), biochemical
data were collected from medical records. Frailty was defined in accordance with the
Edmonton Frail scale (EFS).
RESULTS: In the study, participants’ median age was 69 (range: 65–88) years old, and
median dialysis vintage was 36 (IQR 15–60) months, 20% were aged 75 year old and
older, 53.8% were female. The major causes of the ESRD were hypertension (38.5%)
and diabetes (24.6%). Based on MIS the prevalence of PEW was 73.8%. According to
MNA, the nutritional status was normal in 43.1% of patients, risk of malnutrition was
detected in 47.7%, and malnutrition in 9.2% of patients on MHD. Mean body weight
was 69,1611.3kg, the mean BMI was slightly overweight 25.664.29kg/m2, while hand-
grip strength was 21.3363.36 in men and 15.565.51 in women, p=0.008, and it is
lower than the normal population standard values. CRP was negative in 55.4% of cases.
While MAMC was found to be significantly higher in male patients (24.8761.93cm in
men and 23.3962.76cm in women, p=0.018), TSF was found to be significantly higher
in female patients (9.5663.74mm in men and 16.6867.38cm in women, p<0.001). No
significant difference was observed between genders in the frequency of malnutrition
according to SGA, MNA, MIS, BMI, serum albumin, creatinine.
The prevalence of frailty assessed by the EFS 43.1% were classified as non-frail patients,
33.8% as vulnerable, and 23.1% as frail. Among the frail patients, 86.7% were female
(p=0.005) and 93.3% of frail patients had PEW (p=0.001) evaluated by MIS.
CONCLUSIONS: Protein-energy wasting is common among elderly hemodialysis
patients in Kazakhstan. Its prevalence varies between 56.9% and 73.8% depending on
the measurement tool used to evaluate the nutritional status. In our country with
limited resources, MIS and MNA nutritional scores could help to follow the nutritional
status of our elderly hemodialysis patients. Also the study showed that the prevalence of
frailty is high among female patients, and we detected that PEW increased in female
frail patients.
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INTRODUCTION: Protein energy malnutrition in chronic dialysis patients is very
common, the abnormal appetite may lead to the main cause of malnutrition, the causes
include dry mouth, metallic taste, stomach problems. The purpose of this study is to
explore the correlation of nutritional markers with appetite self-assessments in
peritoneal patients in South Taiwan.
METHODS: we included 136 peritoneal dialysis patients in the study, and divided all
patients into two groups, one group is a poor appetite in appetite self-assessments 28
score, another group is no poor appetite in appetite self-assessments>28 score. Used
7-point subjective global nutritional assessment (SGA), collected anthropometry,
muscle strength, blood biochemical data, and appetite self-assessments.
RESULTS: the poor appetite ( 28 score) in self appetite assessment had 92 patients
(67%). The patients with no poor appetite in appetite self-assessment had significantly
higher mid - arm muscle circumference (MAMC) (23.063.8 vs 21.363.3 cm, P< 0.05)
and mid - arm muscle area (MAMA ) (43.36 14.1 vs 36.8611.2 cm2), hand grip
strength (HGS) (33.469.2 vs 26.069.9 kg, P < 0.05) and pinch strength (PS)
(16.864.5 vs 13.464.4 kg, P< 0.05). In the 7 points SGA, activity score (5.560.9 vs
5.161.1 score, P< 0.05), muscle mass score (5.460.9 vs 5.060.8 score, P< 0.05 ), and
total SGA score (5.36 0.9 vs 4.961.0 score, P< 0.05) in no poor appetite in appetite
self- assessment group had significantly higher than
poor appetite risk in appetite self- assessment group. In blood chemistry data, serum
albumin, creatinine, Hb, HCT% had lower significantly in the poor appetite in self-
assessment group. In appetite self- assessment score, the risk of poor appetite with
dialysis patients had lower in all item score and total appetite score, especially food
taste score (2.961.0 vs 2.60.8 score, P< 0.0005) and hungry score (3.860.7 vs 2.760.8
score, P< 0.0001).
CONCLUSIONS: The peritoneal dialysis patients had higher prevalence in
malnutrition, and lower the score in appetite self- assessment in patients effect
nutrition, and muscle strength, and serum albumin level, those poor appetite patients
should consult nutrition and intervention, even referred to psychotherapist.
FP734 CRP / ALB RATIO AS A STRONG PREDICTOR OF MORTALITY
IN DIALYSIS PATIENTS
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1Masuko memorial hospital, Nagoya, Japan, 2Fujita Health University, Toyoake-shi,
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INTRODUCTION: To examine the association of CRP / Alb ratio and mortality in
dialysis patients.
METHODS: A total of 363 patients (mean age 66 6 12 years) who underwent stable
dialysis therapy (average 8.5 years) were enrolled. GNRI as an established predictor was
set to reference, we examined the association between CRP / Alb ratio and mortality.
RESULTS: During the observation period (median 42 months), 86 patient (23.7%)
died. Analysis was carried out by dividing into tertiles according to the GNRI and the
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